Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Sell
94
-72
-43% -$9.15K ﹤0.01% 441
2026
Q1
$20.1K Buy
166
+110
+196% +$12.4K ﹤0.01% 330
2025
Q4
$5.47K Sell
56
-225
-80% -$20.7K ﹤0.01% 372
2025
Q3
$25.2K Buy
281
+59
+27% +$5.81K ﹤0.01% 429
2025
Q2
$21.9K Buy
222
+57
+35% +$5.47K ﹤0.01% 437
2025
Q1
$17.2K Sell
165
-535
-76% -$66.9K ﹤0.01% 471
2024
Q4
$94.6K Buy
700
+535
+324% +$76.7K 0.02% 275
2024
Q3
$25.7K Hold
165
0.01% 392
2024
Q2
$24.4K Sell
165
-287
-63% -$45.2K 0.01% 390
2024
Q1
$80.1K Sell
452
-55
-11% -$8.37K 0.02% 242
2023
Q4
$72.2K Sell
507
-296
-37% -$36.1K 0.02% 250
2023
Q3
$88.8K Buy
+803
New +$102K 0.04% 118

Other funds holding TGT

Arlington Trust's TGT Position: Q2 2026 in Review

Arlington Trust reduced its Target (TGT) stake by 43% in Q2 2026, selling an estimated $9.15K and leaving 94 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Arlington Trust first reported a position in TGT in Q3 2023 and has held it in 12 quarters since. The position peaked at $94.6K in Q4 2024. 930 funds tracked by Wall St. Rank hold TGT as of Q2 2026.

  • Arlington Trust held 94 shares of Target worth $12.3K as of Q2 2026.
  • Arlington Trust sold 72 Target shares in Q2 2026, an estimated $9.15K.
  • Target made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #441 holding.
  • Arlington Trust first reported a position in Target in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Target position peaked at $94.6K in Q4 2024.
  • 930 funds tracked by Wall St. Rank held Target as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.